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Abstract
Objective: To assess in a prospective trial the influence of the amount of tissue resected at
transurethral resection of the prostate (TURP) for benign prostatic enlargement on the symp-
tom improvement as assessed by symptom scores.
Methods: Between December 1996 and August 1998 a total of 138 men (mean age 68.2, range
53–89) with symptomatic benign prostatic enlargement who underwent TURP participated in
this prospective study. Patients were assessed preoperatively with the International Prostate
Symptom Score (IPSS), the American Urological Association Bother Score (AUA-BS) and the
Benign Prostatic Hyperplasia Impact Index (BPH-II) as well as urinary flow rate measurements
(Qmax) and prostate volume (PV) and residual urine determination by ultrasound. The amount of
tissue resected was weighed. Patients were followed with reevaluation of Qmax, residual urine
and the symptom and bother scores at 3 and 6 months.
Results: A close correlation between preoperative PV (mean 49.0 ml, SD 22.0, range 13–140)
and the resected tissue weight (RTW, mean 24.7 g, SD 18.0, range 6–128) was seen (r = 0.75,
pd0.001). Age was correlated with preoperative PV (r = 0.23, pd0.05). While significant mean
improvements in Qmax, residual volume and IPSS, AUA-BS and BPH-II were found 3 and 6
months postoperatively, a negative correlation was seen between the RTW and the IPSS, the
AUA-BS and the BPH-II 3 months after TURP (r = –0.23, pd0.024; r = –0.23, pd0.025; r = –0.20,
p = 0.05). No statistically significant correlation was seen between symptom change and the
percentage of PV removed or the residual prostatic weight. Classification of the patients into
groups depending on preoperative PV (d30, 31–50, 51–70 and c70 ml) showed a tendency for
patients with larger PV to gain more symptom improvement postoperatively.
Conclusions: Early symptom improvement after TURP will depend on the amount of tissue re-
moved but the relationship is weak and affected by several other confounding factors. Appar-
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depression and/or residual urine volume c100 ml) and written in-
formed consent to participation in this clinical trial. Patients with a
history of previous transurethral surgery of the prostate or prostate
cancer were excluded as were patients with severe neurological dis-
eases.
The trial was conducted according to GCP criteria and approved
by the hospital’s ethics committee.
Patients had been referred by private office urologist or the de-
partment’s outpatient clinic with the indications for TURP given
above. Preoperatively, all patients were evaluated by routine physical
examination including a digital rectal examination, suprapubic ultra-
sound for the determination of prostate and residual urine volume
(Siemens Versaline, Siemens, Munich, Germany) and urinary flow
rate measurements (Dantec Flowmeter, Dantec, Denmark). A routine
laboratory evaluation including prostate-specific antigen evaluation
was done. Symptoms prior to surgery were assessed by a self-admin-
istered questionnaire containing all items of the International Prostate
Symptom Score (IPSS) including the Quality of Life assessment
(QoL), the American Urological Association Bother Score (AUA-BS)
and the BPH Impact Index (BPH-II).
TURP was performed using standard 26-French resectoscopes
(Wolf, Knittlingen, Germany) with the intermittent flow technique, by
four different staff urologists according to the technique of complete
adenoma resection down to the surgical capsule. The tissue resected
was weighed in the operation theater immediately after the completion
of TURP. 24-French irrigation catheters were placed and the balloon
routinely blocked in the prostatic fossa with a volume corresponding to
the amount of tissue removed. Irrigation was maintained until the next
morning, and catheters were removed routinely on the 3rd day follow-
ing TURP. Patients were usually discharged 1 day after catheter re-
moval. On the day of discharge a urinary flow reading was taken.
Follow-up of the study patients was done with examinations 3 and
6 months after TURP, either by the referring office urologists or the
outpatient clinic of the department. Follow-up included a clinical ex-
amination, determinations of flow rates and residual urine volume and
the evaluation of symptom and bother scores using the identical self-
administered questionnaire.
Statistical analysis was done by comparison of means with the 
t test for paired or independent samples, as appropriate. Values are
given as means B SD or SEM, as indicated. Correlation analysis was
done using Spearman’s or Pearson’s correlation coefficient, as appro-
priate.
Results
The mean patient age was 68.22 years (SD 8.08, range
53–89), the mean preoperative prostate volume (PV) was
49.09 ml (SD 22.03, range 6–40) and the mean weight of
the resected tissue (RTW) was 24.75 g (SD 18.06, range
6–128).
Introduction
Transurethral resection of the prostate (TURP) is a safe
and effective procedure [1] and remains the standard surgi-
cal treatment of benign prostatic hyperplasia (BPH) despite
a variety of treatment alternatives [2]. Presently, the out-
come of TURP is assessed in terms of symptom improve-
ment as well as improvement in lower urinary tract function
measured by simple urodynamic investigations of bladder
emtying, i.e. flow rates and residual urine volume. Full uro-
dynamic studies are not a routine investigation before
TURP for most urologists in Germany [3].
The recommended technique of TURP consists of com-
plete removal of all adenomatous tissue. However, the peri-
operative morbidity of TURP in terms of blood loss and flu-
id inflow is related to the size of the prostate. Hence, with
the intention to reduce the morbidity of transurethral resec-
tion, limited resection techniques (minimal TURP, channel
TURP) [4] have therefore been introduced and have gained
some popularity. Other techniques of transurethral BPH
treatment, such as transurethral needle ablation or intersti-
tial laser coagulation do not aim at complete adenoma re-
moval at all but rely on tissue sloughing or shrinkage in
varying degrees [5, 6]. With these different techniques and
approaches to transurethral BPH treatment, the question of
whether complete adenoma removal is required becomes
important again.
While it is well known that there is little correlation be-
tween the size of the prostate gland and clinical measures of
lower urinary tract function or lower urinary tract symp-
toms in BPH, it is not entirely clear as to whether and how
much outcome after TURP is related to the degree of ade-
mona removal which is achieved.
We therefore conducted a prospective trial to determine
the effect of the extent of tissue resection on symptom im-
provement after TURP in men with symptomatic benign
prostatic enlargement.
Patients and Methods
Between December 1996 and August 1998, 138 patients were re-
cruited for this prospective trial. Inclusion criteria were a definite in-
dication for treatment by TURP (i.e. symptomatic benign prostatic en-
largement with moderate-to-severe symptom severity and/or flow rate
ently, the symptomatic improvement after TURP is not primarily dependent on the relative com-
pleteness of the resection. Patients with larger prostates and larger RTW tend to gain more
symptomatic benefit from TURP than do patients with smaller prostates.
Copyright © 2001 S. Karger AG, Basel
414 Eur Urol 2001;39:412–417 Hakenberg/Helke/Manseck/Wirth
The mean pre- and postoperative values of the parame-
ters evaluated are given in table 1. Marked postoperative
improvements were seen in flow rates, residual urine vol-
ume and symptom and bother scores. The Qmax taken on the
day of discharge, 24 h after catheter removal, was 18.28 ml/s
(SD 9.04, range 5.7–48.7). The changes in Qmax, residual
urine volume, IPSS, AUA-BS and BPH-II 3 and 6 months
after TURP compared to preoperative values were marked
and statistically significant (table 1).
Between the follow-up examinations at 3 and 6 months,
no further significant changes in Qmax or residual urine vol-
ume were seen, while significant further improvements in
IPSS, AUA-BS, BPH-II and QoL were noted (table 1).
A significant correlation within the study group was seen
between age and PV (r = 0.28, pd0.006) as well as between
age and RTW (r = 0.29, pd0.002). PV and RTW were high-
ly significantly correlated (r = 0.74, pd0.0001; fig. 1).
There were no significant correlations between PV and ei-
ther Qmax, residual urine volume, symptom or bother scores
preoperatively, while the preoperative Qmax correlated sig-
nificantly with the preoperative IPSS (r = –0.33, pd0.004).
Postoperatively, the RTW showed a significant correla-
tion with the first Qmax recording on the day of discharge
(r = 0.23, pd0.03), but not with the subsequent Qmax mea-
sured at 3 and 6 months postoperatively. The RTW also cor-
related negatively with the symptom and bother evaluation
3 months after TURP (IPSS: r = –0.23, pd0.024; AUA-BS:
r = –0.23, pd0.025; BPH-II: r = –0.19, p = 0.05; fig. 2), but
not with the same parameters at the 6-month follow-up.
A residual prostatic weight ratio (RPWR, %) was calcu-
lated (prostate volume –resected weight/prostate volume),
giving the percentage of the PV remaining after TURP. The
RPWR closely and negatively correlated with the RTW (r =
–0.65, pd0.001) and was higher for smaller resected
weights (fig. 3). The RPWR correlated negatively with age
(r = –0.17, pd0.05) and negatively with the 3-month post-
operative improvement in Qmax (r = –0.27, pd0.05). Al-
though there were weak negative correlations between the
Fig. 1. Correlation between preoperative PV and RTW (linear re-
gression with 95% confidence intervals).
Fig. 2. IPSS at 3-month the follow-up versus RTW. Linear regres-
sion with 95% confidence intervals.
Table 1. Means (BSD) of the evaluated parameters before and 3 and 6 months after TURP
Qmax, ml/s Residual urine, ml IPSS (0–35) AUA-BS (0–28) BPH-II (0–) QoL (0–6)
Preoperative 9.80B5.36 101.7B80.3 16.8B7.4 10.89B6.8 6.14B2.9 3.70B1.4
After TURP
3 months 20.07B9.98b 9.84B17.9a 6.90B6.5b 5.01B6.4b 3.38B3.5b 1.59B1.5b
6 months 23.29B11.27 9.85B23.7 4.93B4.4a 2.32B3.3b 1.73B2.5b 1.15B1.0a
Statistically significant differences compared to the previous measurement (3-month follow-up vs. baseline, 
6-month follow-up vs. 3-month follow-up) (apd0.05, bpd0.01) are indicated.
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RPWR and the postoperative changes as well as the abso-
lute postoperative symptom and bother scores these were
not significant (e.g. RPWR vs. postoperative IPSS improve-
ment at 3 months: r = –0.19, p = 0.083 (fig. 4)).
Subgrouping patients depending on the preoperative
prostate volume into groups with small (d30 ml), medium
(31–50 ml), large (51–70 ml) and very large (c70 ml)
prostates showed significant differences in the mean RTWs
between these groups (pd0.01 for each; table 2). Between
these four groups with increasing PVs, there was no signif-
icant difference in preoperative symptom or bother scores,
Qmax or residual volume, except for the group with the
smallest prostates having a somewhat higher mean IPSS
score preoperatively. There was a tendency for patients with
larger prostates to be older on average and the mean age of
the subgroup with very large prostates was significantly
higher than that of those with small prostates (pd0.05).
Postoperatively, there was a tendency for patients with
larger PVs (and larger RTWs) to have better postoperative
flow rates and lower postoperatives symptom and bother
scores. However, although these tendencies may be seen in
the results given in table 2, only a few of the differences
reached statistical significance (lower postoperative IPSS
and AUA-BS in patients with very large prostates (d70),
lower postoperative residual volume in patients with
prostates sized 51–70 ml).
Discussion
The conventional technique of transurethral resection
aims at complete adenoma removal [7]. However, differ-
ences in individual surgeon’s estimations exist regarding
the extent of tissue removal still enabling uninhibited post-
operative voiding. Thus, the completeness of adenoma re-
moval by TURP is an area that is essentially under the con-
trol of the surgeon and might result in differences in
postoperative outcome. Indeed, incomplete removal of the
adenoma, as long as relief from obstruction is achieved, was
advocated in order to reduce the morbidity of TURP.
There have been few investigations into the influence
which the amount of resected tissue and the completeness of
transurethral resection might have on outcome in BPH. For
the patient, the most important outcome parameter is symp-
tomatic improvement as assessed by symptom and bother
scores [8–10].
In our study group, we found a close correlation between
PV and age and a tendency for older men to have larger
RTWs (table 2). A negative correlation was seen between
postoperative symptoms and RTWs 3 months after TURP,
while there was no correlation between the calculated 
RPWR and symptomatic outcome.
Possible methodological limitations of our study are that
PV was measured by suprapubic rather than transrectal 
ultrasound, that residual prostatic weight was calculated
rather than measured and that follow-up was limited to 6
months.
However, the close correlation between PV and RTW
illustrates that generally both measurements were reliable
and that complete or near complete adenoma resection was
Fig. 3. RPWR (%) versus RTW. Linear regression with 95% confi-
dence intervals.
Fig. 4. IPSS at the 3-month follow-up versus RPWR.
achieved in most cases. While transrectal ultrasonography
is considered to be more accurate than suprapubic ultra-
sound in prostate size determination, definite and similar
limitations of accuracy exist for both methods [11, 12].
The negative correlation seen between the RTW and the
postoperative symptom and bother scores at 3 months sug-
gests that there may be a clinically significant relationship
between these parameters. Figure 2 illustrates that patients
with low RTW tended to have higher postoperative symp-
tom scores. The fact that no such correlations were seen 6
months postoperatively does not necessarily contradict this
conclusion since many other factors (prolonged tissue heal-
ing, scar formation, shrinkage of the prostatic fossa, adap-
tion of the bladder to the altered outflow conditions) will in-
fluence the degree of lower urinary tract symptoms over the
first 6 postoperative months. Individual symptom resolu-
tion after TURP may be prolonged in up to 15% of cases
and can take up to 12 months [13, 14]. The correlations be-
tween RTW and symptom and bother scores at 3 months, al-
though statistically significant, were weak, which also sug-
gests that the relationship is confounded.
Chen et al. [15] have described significant correlations
between the improvement in American Urological Associa-
tion symptom score and the calculated RPWR 4 months 
after TURP in a study group of 40 patients. In our study
group which comprised considerably more patients, howev-
er, a significant correlation was demonstrable only between
postoperative symptoms and the absolute RTW and not the
RPWR.
The RPWR was smaller for larger RTWs in our study
with a close and significant correlation (fig. 3). Thus in larg-
er prostates, absolutely and relatively more tissue was re-
sected and the RPWR was consequently lower. While the
RPWR did not correlate with postoperative symptoms, it
did correlate negatively with the postoperative Qmax.
These findings suggest that symptomatic outcome after
TURP depends on the absolute RTW, i.e. the absolute size
of the prostatic opening created rather than the relative ratio
of resected tissue. Thus, patients with larger absolute RTW
will therefore tend to gain more benefit from a TURP than
those with small prostates, while the RPWR may be of rel-
atively little importance. Supporting this conclusion is the
finding of a significant correlation between the RTW and
the first postoperative flow rate on the day after catheter re-
moval, which was only slightly lower than the mean Qmax
(BSD) 3 months postoperatively (18.2B9.0 vs. 20.07B
9.9 ml/s).
Our hypothesis that symptomatic outcome is dependent
on the absolute amount of tissue resected is further support-
ed by the subgroup analysis based on preoperative prostate
size. This showed a tendency for patients with larger
prostates to gain more symptom improvement after TURP.
Except for the group with very large prostates (c70 ml),
there was a also tendency for better postoperative Qmax with
increasing preoperative prostate size (and hence increasing
RTWs). It may be noted that the group with very large
prostates also had the highest mean age. As detrusor func-
tion tends to become weaker with increasing age, this factor
may be of influence as well and may account for the lower
mean Qmax in this subgroup.
These findings may have implications for the selection
of patients for TURP as well as for the technique of TURP.
Since patients with smaller prostates gain less symptomatic
improvement from TURP than those with larger glands, al-
ternative techniques might be considered in patients with
small glands. For patients with very large glands, a TURP
with limited resection and reduced morbidity may be appro-
priate. These questions should be addressed in future re-
search trials with long-term postoperative follow-up.
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Table 2. Means (BSD) of the evaluated parameters before (pre) and 3 months after TURP (post) in subgroups of patients with small, medium,
large and very large preoperative prostate volumes
Prostate Patients Age RTW Qmax, ml/s Residual volume, ml IPSS (0–35)
volume n years g
pre post pre post pre post
d30 ml 34 65.58B8.53 12.1B5.2 9.98B5.1 17.1B7.4 67.8B49.5 18.7B27.3 19.34B7.3 9.64B8.8
31–50 ml 57 68.70B8.57 21.5B9.3b 10.01B5.8 21.2B8.5 120.5B73.4a 7.9B12.3 15.37B7.7a 5.89B5.7
51–70 ml 28 69.32B6.60 33.2B15.7b 8.36B3.6 23.0B13.3 110.3B111.8 2.2B6.0a 17.40B7.1 6.44B5.3
c70 ml 19 70.57B6.51b 46.7B29.5b 10.82B6.9 16.6B9.2 95.0B81.0 10.2B17.8 15.33B6.2 4.38B2.2b
apd0.05, bpd0.01 vs. the corresponding values for the group with small prostates.
Conclusion
The total amount of tissue removed at TURP for BPH
rather than the RPWR does seem to have an influence on
clinical outcome. This influence is measurable early after
TURP but the correlations are weak and therefore probably
influenced by other factors as well. Patients with larger
prostates and hence larger absolute RTWs benefit more
from a TURP in terms of symptom improvement than pa-
tients with smaller prostates. This may have implications
for the selection of treatment modalities depending on
prostate size.
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